IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novartis AG (NOVN)

CUSIP: H5820Q150 | 29 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ABlackRock, Inc.145,227,6507.1%New 5%+ stakeSep 30, 2026Not yet in a 13F
13G/ABlackRock, Inc.145,227,650
7.1% of class · Sep 30, 2026New 5%+ stake
Not yet in a 13F

Institutional Holders — Q3 2026

Generali Investments CEE, investicni spolecnost, a.s.15,729
0.1% of portfolio›$2.5M
StyleTurnoverLocationFiled
Generali Investments CEE, investicni spolecnost, a.s.
15,729$2.5M0.1%CoreLowPrague, Bahrain2026-10-15